• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of oxidized LDL/LOX-1 in the development and progression of renal disease.

Research Project

Project/Area Number 12470209
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionThe University of Tokyo

Principal Investigator

FUJITA Toshiro  Faculty of Medicine, Department of Nephrology and Endocrinology, Professor, 医学部附属病院, 教授 (10114125)

Co-Investigator(Kenkyū-buntansha) SHIMOSAWA Tatsuo  Faculty of Medicine, Department of Nephrology and Endocrinology, Research Associate, 医学部附属病院, 助手 (90231365)
TAKAHASHI Katsutoshi  Faculty of Medicine, Department of Nephrology and Endocrinology, Research Associate, 医学部附属病院, 助手 (00292863)
KANAME Shinya  Faculty of Medicine, Department of Nephrology and Endocrinology, Research Assciate, 医学部附属病院, 助手 (60224581)
長瀬 美樹  東京大学, 医学部・附属病院, 客員研究員 (60302733)
Project Period (FY) 2000 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥14,100,000 (Direct Cost: ¥14,100,000)
Fiscal Year 2002: ¥4,000,000 (Direct Cost: ¥4,000,000)
Fiscal Year 2001: ¥4,400,000 (Direct Cost: ¥4,400,000)
Fiscal Year 2000: ¥5,700,000 (Direct Cost: ¥5,700,000)
KeywordsLOX-1 / Renal Damage / Angiotensin II / Atherosclerosis / Hypertension / Oxidative Stress / TGFβ / Renal Intestitial / oxidized LDL / Dahl Rat / PRARγ / Redox / Diahetes / flk-1 / tie2 / Hypertension / Kidney / Nephrosclerosis / Salt / mineralocorticoid / transgenic rat
Research Abstract

Lectin-like oxidized LDL receptor (LOX-1), which has been firstly demonstrated to be oxidized LDL receptor in vascular endothelial cells, has reported to be enhanced in vasculature of model animals of common diseases that cause atherosclerosis. In fact, LOX-1 increases the expression of several factors relevant to atherosclerosis. Thus, LOX-1 has been considered to play an important role of the pathophysiology of atherosclerosis. We focused the role of LOX-1 in the development of renal damage. We demonstrated that renal LOX-1 expression was increased in salt-loaded Dahl salt-sensitive rats, which are well-known hypertensive renal damage model. In contrast, renal LOX-1 was not enhanced in spontaneously hypertensive rats, in which blood pressure was similarly elevated without renal dysfunction. Moreover, renal LOX-1 expression was stimulated in the other renal damage models such as 5/6-nephrectomized rats and unilateral urethral obstruction mice. Subacute TNFα stimulation also enhance renal LOX-1 expression. Therefore, LOX-1 may be important in the development of any kinds of renal damage. Also, agents to inhibit the renin-angiotensin system and antioxidants ameliorated renal damage associated with reduction of LOX-1 expression. Thus, angiotensin II and oxidative stress may attribute to the development of renal damage through increase in LOX-1 expression.

Report

(4 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Nagase M, Kaname S, Nagase T, Wang G, Ando K, Fujita T: "Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis"Journal of American Society of Nephrology. 11. 1826-1836 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T: "Redox-sensitive regulation of LOX-1 gene expression in vascular endothelium"Biochemical Biophysical Research Communication. 281. 720-725 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chiba Y, Ogita T, Ando K, Fujita T: "PPARγ ligands inhibit THFα-induced LOX-1 expression in cultured endothelial cells"Biochemical Biophysical Research Communication. 286. 541-546 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chen M, Nagase M, Fujita T, Narumiya S, Masaki T, Sawamura T: "Diabetes enhances lectin-like oxidized LDL receptor-1 (lox-1) expression in the vascular endothelium : possible role of lox-1 ligand and age"Biochemical Biophysical Research Communication. 287. 962-968 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chiba Y, Ando K, Fujita T: "The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats"Journal of Hypertension. 20. 2269-2274 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ueno T, Kaname S, Takaichi K, Nagase M, Tojo A, Onozato ML, Fujita T: "LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidney of chronic renal failure rats"Hypertension Research. 26. 117-122 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nagase M, Kaname S, Nagase T, Wang G, Ando K, Fuiita T: "Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis"Journal of American Society of Nephrology.. 11. 1826-1836 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T: "Redox-sensitive regulation of LOX-1 gene expression in vascular endothelium"Biochemical Biophysical Research Communication.. 281. 720-725 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chiba Y, Ogita T, Ando K, Fujita T: "PPARγ ligands inhibit THFα-induced LOX-1 expression in cultured endothelial cells"Biochemical Biophysical Research Communication.. 286. 541-546 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chen M, Nagase M, Fujita T, Narumiya S, Masaki T, Sawamura T: "Diabetes enhances lectin-like oxidized LDL receptor-1 (lox-1) expression in the vascular endothelium : possible role of lox-1 ligand and age"Biochemical Biophysical Research Communication.. 287. 962-968 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chiba Y, Ando K, Fuiita T: "The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats"Journal of Hypertension. 20. 2269-2274 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ueno T, Kaname S, Takaichi K, Nagase M, Tojo A, Onozato ML, Fujita T: "LOX-1, an oxidized low-density lipoprotein receptor, was unregulated in the kidney of chronic renal failure rats"Hypertension Research. 26. 117-122 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chiba Y, Ando K, Fujita T: "The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats"Journal of Hypertension. 20. 2269-2274 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ueno T, Kaname S, Takaichi K, Nagase M, Tojo A, Onozato ML, Fujita T: "LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidney of chronic renal failure rats"Hypertension Research. 26. 117-122 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tojo A, Onozato LM, Kobayashi N, Goto A, Matsuoka H, Fujita T: "Angiotensin II and Oxidative Stress in Dahl Salt-Sensitive Rat With Heart Failure"Hypertension. 40. 834-839 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, Ando K, Fujita T: "Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage"Circualtion. 105. 106-111 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Chabrashvili T, Tojo A, Onozato M, Kitiyakara C, Quinn M, Fujita T, Wilcox CS: "Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney"Kidney International. 61. 186-194 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yamazaki M, Kawai J, Nakaoka T, Ogita T, Tojo A, Fujita T: "Adrenomedullin overexpression to limit arterial intimal formation induced by cuff placement"Hypertension. 41. 302-307 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Chiba Y, et al.: "PRARγ Ligands inhibit TNFα-induced LOX-1 expression in cultured endothelial cells"Biochem Biophys Res Commun. 286. 541-546 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nagase M, et al.: "Redox-sensitive regulation of LOX-1 gene expression in vascular endothelial cells"Biochem Biophys Res Commun. 281. 720-725 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Chen M, et al.: "Diahetes enhances lectin-like oxidized LDL receptor-1 (COX-1) expression in the vascular endothelium"Biochem Biophys Res Commun. 287. 962-968 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nagase M., et al: "Expression of LOC-1 an oxidized low-density ipoprotein receptor in experimental hypertensive Homeokissos"J.Am Soc Nophrol. 11,10. 1826-1836 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi